Axcelis Technologies, Inc. ACLS
123.11
6.97
6.00%
as of 25 Sep
- Market cap
- $3.6B
- P/E
- 41.0×
Follow ACLS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
63.15 | 28.82 | 21.03 | 22.97 |
+8 more quarters Free account |
P/S ratio |
6.74 | 3.38 | 3.02 | 3.58 | |
P/FCF ratio |
89.03 | 32.32 | 23.70 | 24.63 | |
P/Operating CF |
317.64 | 157.65 | (386.27) | 67.36 | |
P/B ratio |
5.48 | 2.74 | 2.45 | 2.99 | |
Price to Tangible BV |
5.48 | 2.74 | 2.45 | 2.99 | |
EV/Sales |
6.34 | 3.01 | 2.64 | 3.12 | |
EV/EBITDA |
52.69 | 22.68 | 16.70 | 17.80 | |
EV/Operating CF |
72.89 | 26.36 | 18.75 | 19.33 | |
EV/FCF |
83.72 | 28.80 | 20.72 | 21.45 | |
Quick Ratio |
2.78 | 2.59 | 2.75 | 3.00 | |
Current Ratio |
4.90 | 4.59 | 4.77 | 4.95 | |
Net Debt/EBITDA |
(15.32) | (26.26) | (8.38) | (14.45) | |
Debt/Assets |
2.87% | 2.93% | 2.99% | 3.04% | |
Debt/Equity |
0.04 | 0.04 | 0.04 | 0.04 | |
Asset Turnover |
0.64 | 0.62 | 0.62 | 0.63 | |
Operating CF/Net income |
0.79 | 1.97 | (0.19) | 1.75 | |
Capex/Depreciation |
(1.05) | (0.41) | (0.64) | (0.62) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
13.47% | 14.33% | 12.64% | 11.53% | |
Selling, General and Administrative Expense of Revenue |
19.49% | 22.17% | 19.15% | 18.33% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.99% | 2.46% | 2.14% | 2.50% | |
Graham Net Nets |
0.11 | 0.21 | 0.24 | 0.21 | |
Graham Number |
48.33 | 49.71 | 53.07 | 55.84 | |
Earnings Yield |
1.58% | 3.47% | 4.75% | 4.35% | |
Free Cash Flow Yield |
1.12% | 3.09% | 4.22% | 4.06% | |
Revenue per Share |
6.99 | 6.48 | 7.55 | 6.83 | |
Operating CF per Share |
0.60 | 0.59 | (0.21) | 1.45 | |
Capex per Share |
(0.12) | (0.06) | (0.07) | (0.06) | |
Free Cash Flow per Share |
0.48 | 0.53 | (0.28) | 1.39 | |
Cash per Share |
13.06 | 11.93 | 11.85 | 14.37 | |
Shareholders Equity per Share |
34.60 | 34.00 | 32.77 | 32.61 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
34.60 | 34.00 | 32.77 | 32.61 | |
Free Cash Flow |
14.82 | 16.30 | (8.90) | 43.34 | |
Working Capital |
779.67 | 731.77 | 745.54 | 785.04 | |
Capital Expenditures |
(3.55) | (1.84) | (2.33) | (2.01) | |
Net Current Asset Value |
658.75 | 605.78 | 616.53 | 652.23 | |
EV/EBIT |
61.37 | 25.97 | 18.59 | 19.33 | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
10.82% | 4.63% | 14.39% | 12.17% | |
Price to Operating Income |
65.26 | 29.15 | 21.26 | 22.19 | |
| Other line items | |||||
Average Receivables |
146.50 | 163.38 | 185.81 | 165.59 | |
Average Payables |
47.96 | 45.27 | 44.62 | 53.26 | |
Average Inventory |
324.47 | 310.95 | 305.62 | 307.65 | |
Average Assets |
1,355.16 | 1,357.58 | 1,355.07 | 1,345.03 | |
Average Common Equity |
1,044.10 | 1,035.94 | 1,023.73 | 997.87 |
Columns are period end dates